|Vestel Ventures||Turkey, Sisli|
|Kip||United States, New York|
|Valiance Asset Management||Guernsey, Castel|
|Concentra Bank||Canada, Saskatoon|
|TD Veen||Norway, Stavanger|
|Atreides Capital||United States, Houston|
|Goldman Sachs Bank USA||United States, New York|
|Makerpad||United Kingdom, Cardiff|
|Bravia Capital||China, Hong Kong Island|
|Zhuhai Hengqin Xinqu Hongliangyu Xiongdi Touzi Zixun Hehuo Qiye||China, Zhuhai|
|DCVC Bio||United States, San Francisco|
|Ruiyun Xinxi||China, Guangdong|
|USAID East Africa Trade and Investment Hub||-|
|Yishi Medical Industry Investment Holdings||China, Beijing|
|Talisman Capital Partners||United States, Columbus|
|Yipeng Zichan||China, Jiading District|
|Scrum Software||Japan, Fukuoka|
|I-Source Gestion||France, Paris|
|$1M||24 Apr 2012||China, Qingdao City|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.